EP Patent

EP0752245A1 — Biocompatible and biodegradable nanoparticles designed for proteinaceous drugs absorption and delivery

Assigned to European Community · Expires 1997-01-08 · 29y expired

What this patent protects

A polymer blend obtainable by a process comprising the steps of intimate mixing a biocompatible polymer able to form nanoparticles and a biocompatible interacting agent for making the polymeric blend susceptible for a drug to be administered which interacting agent is able…

USPTO Abstract

A polymer blend obtainable by a process comprising the steps of intimate mixing a biocompatible polymer able to form nanoparticles and a biocompatible interacting agent for making the polymeric blend susceptible for a drug to be administered which interacting agent is able to preserve the activity of the drug to be administered and which interacting agent is able to control the release of the drug to be administered.

Drugs covered by this patent

Patent Metadata

Patent number
EP0752245A1
Jurisdiction
EP
Classification
—
Expires
1997-01-08
Drug substance claim
No
Drug product claim
No
Assignee
European Community
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.